Huang Yixiang, Jian Wei, Zhao Junyong, Wang Gang
Department of General Surgery, Tenth People's Hospital of Tongji University, Shanghai, China.
Onco Targets Ther. 2018 Apr 17;11:2177-2184. doi: 10.2147/OTT.S164583. eCollection 2018.
Breast cancer represents a serious health issue among females. has been identified as an oncogene in human cancers. This study sought to assess the prognostic value and the biologic function of in breast cancer patients.
Expression of in breast cancer tissues and cells was evaluated by quantitative real-time polymerase chain reaction. Kaplan-Meier survival analysis and Cox regression assay were conducted to explore the prognostic significance of . Cell experiments were performed to investigate the effects of on the biologic behaviors of breast cancer cells.
Expression of was significantly upregulated in both cancerous tissues and cells compared with the normal controls (all <0.05). Overexpression of was correlated with lymph node metastasis (=0.021) and TNM stage (=0.004). Patients with high had poor overall survival compared to those with low levels of (log-rank <0.05). Elevated was found to be an independent prognostic factor for the patients (hazard ratio=2.996, 95% CI=1.611-5.572, =0.001). According to the cell experiments, tumor cell proliferation, migration and invasion were suppressed by knockdown of .
All data demonstrated that overexpression of serves as a prognostic biomarker and may be involved in the tumor progression of breast cancer.
乳腺癌是女性中的一个严重健康问题。已被确定为人类癌症中的一种癌基因。本研究旨在评估其在乳腺癌患者中的预后价值和生物学功能。
通过定量实时聚合酶链反应评估乳腺癌组织和细胞中的表达。进行Kaplan-Meier生存分析和Cox回归分析以探讨的预后意义。进行细胞实验以研究对乳腺癌细胞生物学行为的影响。
与正常对照相比,癌组织和细胞中的表达均显著上调(均<0.05)。的过表达与淋巴结转移(=0.021)和TNM分期(=0.004)相关。高表达患者的总生存期低于低表达患者(对数秩<0.05)。发现升高是患者的独立预后因素(风险比=2.996,95%可信区间=1.611-5.572,=0.001)。根据细胞实验,敲低可抑制肿瘤细胞的增殖、迁移和侵袭。
所有数据表明,的过表达作为一种预后生物标志物,可能参与乳腺癌的肿瘤进展。